[1]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21-24.
 Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):21-24.
点击复制

自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第26卷
期数:
2014年09期
页码:
21-24
栏目:
临床研究
出版日期:
2014-09-30

文章信息/Info

Title:
Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis
作者:
李明徐明雄冯左基胡建强郝涛贾舜祝海滨夏文波东光彬
山东省青岛市黄岛区中医医院,山东 青岛 266500
Author(s):
Li Ming*Xu MingxiongFeng ZuojiHu JianqiangHao TaoJia ShunZhu HaibinXia WenboDong Guangbin.
*Traditional Chinese Medicine Hospital of Huangdao,Qingdao 266500,Shandong,China
关键词:
骨质疏松绝经后 壮骨方 骨密度 雌二醇 治疗临床研究性
Keywords:
Osteoporosispostmenopausal ZHUANGGU decoction Bone density Estradiol Therapiesinvestigational
摘要:
目的:探讨自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制。方法:将纳入研究的240例绝经后骨质疏松症患者随机分为2组,每组120例。治疗组采用口服自拟壮骨方治疗,对照组采用口服尼尔雌醇片治疗。比较2组患者的骨密度及血清中钙、磷、碱性磷酸酶、雌二醇的水平,同时比较2组患者治疗后的疼痛改善情况。结果:①骨密度。治疗前2组患者腰椎和股骨颈骨密度比较,组间差异均无统计学意义[(0.73±0.26)g·cm-2,(0.71±0.29)g·cm-2,t=3.296,P=0.110;(0.84±0.03)g·cm-2,(0.85±0.02)g·cm-2,t=3.114,P=0.201]。治疗组治疗前后腰椎骨密度的差值大于对照组[(0.20±0.15)g·cm-2,(0.18±0.12)g·cm-2,t=4.012,P=0.021]; 2组患者股骨颈骨密度的差值比较,差异无统计学意义[(0.60±0.24)g·cm-2,(0.16±0.14)g·cm-2,t=1.062,P=0.080]。②血生化指标。治疗前2组患者血清中钙、磷、碱性磷酸酶、雌二醇浓度比较,组间差异均无统计学意义[(2.24±0.16)mmol·L-1,(2.22±0.14)mmol·L-1,t=5.659,P=0.431;(1.19±0.21)mmol·L-1,(1.18±0.22)mmol·L-1,t=3.314,P=0.158;(109.50±13.41)U·L-1,(108.71±20.42)U·L-1,t=1.354,P=0.762;(40.86±18.26)pmol·L-1,(41.14±19.04)pmol·L-1,t=1.918,P=0.656]。治疗组血清中钙和磷浓度治疗前后的差值均大于对照组[(1.61±0.46)mmol·L-1,(0.31±0.25)mmol·L-1,t=5.618,P=0.000;(0.60±0.24)mmol·L-1,(0.30±0.14)mmol·L-1,t=7.012,P=0.000]; 碱性磷酸酶和雌二醇浓度治疗前后的差值与对照组比较,差异均无统计学意义[(20.21±12.16)U·L-1,(16.11±10.12)U·L-1,t=1.368,P=0.612;(19.26±10.23)pmol·L-1,(16.76±9.67)pmol·L-1,t=1.386,P=0.748]。③疼痛改善情况。治疗组显效74例、有效35例、无效11例,对照组显效71例、有效34例、无效15例。治疗结束后2组患者疼痛改善情况比较,差异无统计学意义(Z=-0.547,P=0.584)。结论:自拟壮骨方具有类雌激素样作用,可通过提高雌激素水平,改善骨代谢,增加骨密度,减轻绝经后骨质疏松症患者的疼痛症状。
Abstract:
Objective:To study the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis(PMO).Methods:Two hundred and forty patients with PMO were randomly divided into 2 groups,120 cases in each group.The patients in the treatment group was treated with oral application of self-made ZHUANGGU decoction,while others in the control group was treated with nilestriol tablet.Bone mineral density(BMD)and serum level of Ca,P,alkaline phosphatase(ALP)and estradiol(E2)were compared between the 2 groups.Meanwhile,the posttreatment pain degree was compared between the 2 groups.Results:There was no statistical difference in BMD of lumbar spine and femoral neck between the 2 groups before the treatment(0.73+/-0.26 vs 0.71+/-0.29 g/cm(2),t=3.296,P=0.110; 0.84+/-0.03 vs 0.85+/-0.02 g/cm(2),t=3.114,P=0.201).After the treatment,the lumbar spine BMD change of treatment group was greater than that of control group(0.20+/-0.15 vs 0.18+/-0.12 g/cm(2),t=4.012,P=0.021),and there was no statistical difference in the femoral neck BMD change between the 2 groups(0.60+/-0.24 vs 0.16+/-0.14 g/cm(2),t=1.062,P=0.080).There was no statistical difference in serum level of Ca,P,ALP an E2 between the 2 groups before the treatment(2.24+/-0.16 vs 2.22+/-0.14 mmol/L,t=5.659,P=0.431; 1.19+/-0.21 vs 1.18+/-0.22 mmol/L,t=3.314,P=0.158; 109.50+/-13.41 vs 108.71+/-20.42 U/L,t=1.354,P=0.762; 40.86+/-18.26 vs 41.14+/-19.04 pmol·L-1,t=1.918,P=0.656).After the treatmeng,the change of serum level of Ca and P of treatment group was greater than that of control group(1.61+/-0.46 vs 0.31+/-0.25 mmol/L,t=5.618,P=0.000; 0.60+/-0.24 vs 0.30+/-0.14 mmol/L,t=7.012,P=0.000),while there was no statistical difference in the change of serum level of ALP and E2 between the 2 groups(20.21+/-12.16 vs 16.11+/-10.12 U/L,t=1.368,P=0.612; 19.26+/-10.23 vs 16.76+/-9.67 pmol/L,t=1.386,P=0.748).Seventy-four patients obtained an excellent result,35 good and 11 poor in the treatment group; while 71 patients obtained an excellent result,34 good and 15 poor in the control group.There was no statistical difference in the degree of pain relief between 2 groups after the treatment(Z=-0.547,P=0.584).Conclusion:Self-made ZHUANGGU decoction has estrogen-like effects,so it can effectively reduce the pain symptoms of the patients with PMO through increasing estrogen levels and improving bone metabolism and increasing BMD.

参考文献/References:

[1] 张鑫,刘波,刘辉,等.骨质疏松症的诊断标准及其相关影响因素[J].中医正骨,2012,24(3):33-35.
[2] 何成奇,熊淑芳,谢薇,等.渐进抗阻运动与短暂最大收缩疗法治疗骨质疏松腰背疼痛的临床研究[J].华西医学,2003,18(2):169-170.
[3] 刘忠厚.中国人原发性骨质疏松症诊断标准(试行)[J].中国骨质疏松杂志,1999,5(1):4-6.
[4] 熊根玉,曾秀娟,张学学,等.疼痛评估记录的临床应用研究[J].实用疼痛学杂志,2008,4(1):31-34.
[5] 黄建武,黄建华,林爱菊.补肾健骨汤合阿伦磷酸钠对绝经后骨质疏松症患者骨密度和性激素水平的影响[J].中医正骨,2013,25(8):30-31.
[6] 宋玲,李刚.仙灵骨葆治疗原发性骨质疏松症的临床研究[J].中国中医骨伤科杂志,2009,17(3):40-41.
[7] 李学朋.傲骨胶囊对去卵巢大鼠骨质疏松相关检测指标的影响[J].中医正骨,2013,25(1):19-22.
[8] 季晖,刘康,龚晓健,等.淫羊藿总黄酮对摘除卵巢大鼠骨质疏松症的防治作用[J].中国骨质疏松杂志,2001,7(1):8-12.
[9] 张贵林,王长松,唐俊杰,等.含骨松宝的老龄大鼠血清对兔成骨细胞增殖作用的实验研究[J].中国中西医结合杂志,2003,23(8):606-608.
[10] 李芳芳,宋士军,李建平,等.淫羊藿对成骨细胞增殖分化的影响[J].中国骨质疏松杂志,1999,5(2):72.
[11] 谢雁鸣,秦林林,于向东,等.骨碎补、淫羊藿、菟丝子总黄酮对成骨细胞体外培养影响的比较研究[J].中国中医药信息杂志,2005,12(7):22-24.
[12] 韩立民,刘波,徐彭.淫羊藿对成骨细胞增殖的血清药理学研究[J].中医药学刊,2003,21(5):678-680.
[13] 郑洪军,吕振华,胡有谷,等.淫羊藿对体外培养破骨细胞的影响[J].中华实验外科杂志,2000,17(5):76-77.
[14] 樊粤光,黄永明,曾意荣,等.骨碎补提取液对体外分离破骨细胞性骨吸收的作用[J].中国中医骨伤科杂志,2003,11(6):4-6.
[15] 林晓生,曹顺海,王健.黄芪及其制剂对骨质疏松症的治疗作用[J].中医正骨,2008,20(7):77-78.
[16] 刘海江,王小平,林娟,等.淫羊藿苷和黄芪苷Ⅰ对骨髓基质细胞增殖及成骨能力的影响[J].中药材,2006,29(10):1062-1065.
[17] 蔡西国,赵素霞.菟丝子黄酮干预去卵巢大鼠骨代谢研究[J].中药药理与临床,2007,23(6):27-29.

相似文献/References:

[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的 胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
 HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
 LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统 在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
 Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证 患者骨密度的影响[J].中医正骨,2013,25(11):19.
 Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(09):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
 Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(09):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
 Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):5.
[9]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的 相关性研究[J].中医正骨,2012,24(04):16.
 CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(09):16.
[10]许超,肖鲁伟,吴承亮.绝经后女性骨质疏松症辨证分型与抑郁焦虑的关系研究[J].中医正骨,2011,23(12):3.
 XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(09):3.

更新日期/Last Update: 2014-09-30